SCHEMBL7748738

SCHEMBL7748738

COc1cc(C=NNC(=N)NOC(C)=O)c(Br)c(OC)c1OC

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.54
PARP2 Q9UGN5 1/20 0.54
MAPT P10636 3/20 0.49
KDM4E B2RXH2 5/20 0.46
LMNA P02545 3/20 0.46
HPGD P15428 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
POLB P06746 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 1/20 0.39
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5574505 0.85 PARP1 (0.57) PARP1PARP2MAPTKDM4ELMNA
SCHEMBL5574511 0.85 PARP1 (0.57) PARP1PARP2MAPTKDM4ELMNA
Acetic Acid SCHEMBL7748731 0.85 PARP1 (0.58) PARP1PARP2MAPTKDM4ELMNA
Acetic Acid SCHEMBL7748734 0.85 PARP1 (0.58) PARP1PARP2MAPTKDM4ELMNA
SCHEMBL7743153 0.83 PARP1 (0.64) PARP1PARP2MAPTKDM4ELMNA
SCHEMBL7743155 0.83 PARP1 (0.64) PARP1PARP2MAPTKDM4ELMNA
SCHEMBL916162 0.82 KDM4E (0.61) PARP1PARP2MAPTKDM4ELMNA
SCHEMBL917029 0.82 HPGD (0.58) MAPTKDM4ELMNAHPGDSMN1; SMN2
SCHEMBL915015 0.79 MAPT (0.55) MAPTKDM4ELMNAHPGDSMN1; SMN2
SCHEMBL915133 0.78 MAPT (0.49) MAPTKDM4ELMNAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001025192-A1 GUANIDINE DERIVATIVES AND THEIR USE IN THE PRODUCTION OF A MEDICAMENT FOR BLOCKING XANTHINE OXIDASE/DEHYDROGENASE MELACURE THERAPEUTICS AB (SE) 2001-04-12 WO disclosed